bioRxiv ScienceSearch

bioRxiv · 10.1101/2021.03.27.436534

Resting-state based prediction of task-related activation in patients with disorders of consciousness

Abstract

BackgroundAssessment of the level of awareness of people with disorders of consciousness (DOC) is clinically challenging, motivating several studies to combine brain imaging with machine learning to improve this process. While this work has shown promise, it has limited clinical utility, as misdiagnosis of DOC patients is relatively high. As machine learning algorithms rely on accurately labelled data, any error in diagnosis will be learned by the algorithm, resulting in an equally limited diagnostic tool. The goal of the present study is to overcome this problem by stratifying patients, not by diagnosis, but by their capacity to perform volitional tasks during functional magnetic resonance imaging (fMRI) scanning. MethodsA total of 71 patients were assessed for inclusion. They were excluded for the final analysis if they had large focal brain damage, excessive head motion during scanning, or suboptimal MRI preprocessing. Patients underwent both resting-state and task-based fMRI scanning. Univariate fMRI analysis was performed to determine if an individual patient had brain activity consistent with having retained volitional capacity (VC). Differences in resting brain network connectivity between patients with VC and patients without volitional capacity (non-VC) were measured. Connectivity data was then entered as input to a deep learning framework. We used a deep graph convolutional neural network (DGCNN) on connectivity data to identify a specific brain network that most significantly differentiates patients. FindingsWe included 30 patients in our final analysis. Univariate analysis revealed that 13 patients displayed signs of VC, while 17 did not. We found that resting-state connectivity between frontoparietal control and salience network was significantly different between VC and non-VC patients (T(28) = 3.347, p = 0.0023, Bonferroni corrected p = 0.042). Furthermore, we found that using frontoparietal control network connectivity as input to the DGCNN resulted in the best classification performance (test accuracy = 0.85; ROC AUC = 0.92). InterpretationWe found that the DGCNN performed best at discriminating between patients with VC when using only the frontoparietal control network as input to the model. The use of this deep learning method is a significant advance since its inherent flexibility permits the inclusion of both whole-brain and network-specific properties as input, allowing us to classify patients as either having or not having VC. This inclusion of multi-scale inputs (e.g. whole-brain and network-level) facilitates model interpretability and increases our understanding of the neurobiology of DOC. The results propose that the integrity of frontoparietal control network, a brain network well known to play a key role in executive functions and cognitive control, is essential for volitional capacity preservation in patients with DOC. The study also lays groundwork for development of a biomarker to aid in the diagnosis of DOC patients. RESEARCH IN CONTEXTO_ST_ABSEvidence before this studyC_ST_ABSDisorders of consciousness (DOC) are a group of severe brain disorders characterised by damage to the neural systems underlying wakefulness and awareness. DOC are often caused by traumatic brain injury, hypoxia, or neurodegenerative diseases. The motor and cognitive impairments in DOC patients make providing an accurate diagnosis very challenging. Diagnosis is primarily made at the bedside by assessing a patients response to motor commands.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Craig, M. M., Pappas, I., Allanson, J., Finoia, P., Williams, G., Pickard, J. D., Menon, D., Stamatakis, E.. 2021-03-29. Resting-state based prediction of task-related activation in patients with disorders of consciousness. https://doi.org/10.1101/2021.03.27.436534

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience